Explore more publications!

Health Press Barbados: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Press Barbados.

November 2025

December 2025

January 2026

Press releases published on January 16, 2026

DBV Technologies Announces €166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing

January 16, 2026

DBV Technologies Announces €166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing

GlobeNewswire

DBV Technologies annonce avoir reçu un produit brut de 166,7 millions d'euros suite à l'exercice intégral des Bons de Souscription (BS) issus des ABSAs et des BS issus des PFW-BS-PFW émis dans le cadre de son financement de mars 2025

January 16, 2026

DBV Technologies annonce avoir reçu un produit brut de 166,7 millions d'euros suite à l'exercice intégral des Bons de Souscription (BS) issus des ABSAs et des BS issus des PFW-BS-PFW émis dans le cadre de son financement de mars 2025

GlobeNewswire

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

January 16, 2026

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

January 16, 2026

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 16, 2026

Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency

January 16, 2026

Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency

GlobeNewswire

Zenas BioPharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

January 16, 2026

Zenas BioPharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

January 16, 2026

CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Coherent Launches AxioView™ Imaging Fiber Assemblies for OCT and Multimodal Medical Catheters

January 16, 2026

Coherent Launches AxioView™ Imaging Fiber Assemblies for OCT and Multimodal Medical Catheters

GlobeNewswire

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 16, 2026

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 16, 2026

Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Corvus Pharmaceuticals to Announce Results from Cohort 4 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis

January 16, 2026

Corvus Pharmaceuticals to Announce Results from Cohort 4 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis

GlobeNewswire

Tiziana Life Sciences Announces Closing of Oversubscribed $8.8 Million Registered Direct Offering of Ordinary Shares

January 16, 2026

Tiziana Life Sciences Announces Closing of Oversubscribed $8.8 Million Registered Direct Offering of Ordinary Shares

GlobeNewswire

First U.S. Patient Dosed in BiPASS: Phase 3 Prostate Cancer Diagnosis Study

January 16, 2026

First U.S. Patient Dosed in BiPASS: Phase 3 Prostate Cancer Diagnosis Study

GlobeNewswire

$Genmab Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)$

January 16, 2026

Genmab Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

GlobeNewswire

MicroTransponder Joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation

January 16, 2026

MicroTransponder Joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation

GlobeNewswire

AutomateNexus Voice Launches AI-Powered Virtual Receptionist to Help Small Businesses Capture Every Lead

January 16, 2026

AutomateNexus Voice Launches AI-Powered Virtual Receptionist to Help Small Businesses Capture Every Lead

GlobeNewswire

Baylor Genetics Supports Bipartisan House Bill to Broaden Medicaid Access to Genomic Sequencing for Children who Meet Medical Criteria

January 16, 2026

Baylor Genetics Supports Bipartisan House Bill to Broaden Medicaid Access to Genomic Sequencing for Children who Meet Medical Criteria

GlobeNewswire

OneMedNet Delivers a Real-World Data feed of 1.5M Patients consisting of 4M encounters

January 16, 2026

OneMedNet Delivers a Real-World Data feed of 1.5M Patients consisting of 4M encounters

GlobeNewswire

Palisade Bio Announces Two Abstracts Selected for Poster Presentations at Leading Global Inflammatory Bowel Disease Conferences

January 16, 2026

Palisade Bio Announces Two Abstracts Selected for Poster Presentations at Leading Global Inflammatory Bowel Disease Conferences

GlobeNewswire